Objective: To generate a Chinese general population-based threelevel EuroQol five-dimensios (EQ-5D-3L) social value set using the time trade-off method. Methods: The study sample was drawn from five cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and Nanjing, using a quota sampling method. Utility values for a subset of 97 health states defined by the EQ-5D-3L descriptive system were directly elicited from the study sample using a modified Measurement and Valuation of Health protocol, with each respondent valuing 13 of the health states. The utility values for all 243 EQ-5D-3L health states were estimated on the basis of econometric models at both individual and aggregate levels. Various linear regression models using different model specifications were examined to determine the best model using predefined model selection criteria. Results: The N3 model based on ordinary least square regression at the aggregate level yielded the best model fit, with a mean absolute error of 0.020, 7 and 0 states for which prediction errors were greater than 0.05 and 0.10, 
Introduction
Cost-utility analysis (CUA) is an increasingly used form of economic evaluation in health technology assessment. In CUA, health outcomes are measured using a single common measure, quality-adjusted life-years (QALYs), which is based on both life-years and the quality of life gained during the life-years. The quality of life for QALY calculation should be measured on a utility scale on which 1.0 corresponds to full health and 0.0 corresponds to death. Utility of health outcomes can be directly measured using the visual analog scale, time trade-off (TTO), or standard gamble method; however, these elicitation methods are difficult for both researchers and respondents. An alternative approach is to use the preference-based healthrelated quality of life instruments [1] . Examples are the Health Utilities Index [2, 3] , three-level EuroQol five-dimensions (EQ-5D-3L) [4] , five-level EQ-5D [5] , and the Short-Form six-dimensions (SF-6D) derived from the short-form 36 health survey [6] .
The EQ-5D-3L is a simple but widely used instrument in CUA. It provides utility values for a total of 243 unique health states described using a system comprising five dimensions (i.e., mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and three levels (i.e., 1 ¼ no problems, 2 ¼ some/ moderate problems, and 3 ¼ extreme problems) for each dimension. The utility values for the EQ-5D-3L health states are measured from the general population using TTO. With such values available, the utility of any health outcome can be derived simply by describing the health outcome using the EQ-5D-3L system. Because the utility of EQ-5D-3L health states may be affected by culture [7, 8] , many countries such as the United Kingdom, the United States, and Japan have developed their national EQ-5D-3L value sets.
The EQ-5D-3L has been recommended as a tool for conducting health technology assessment in China by China Guidelines for Pharmacoeconomic Evaluations 2011 [9] and its descriptive system, the EQ-5D-3L self-report questionnaire, has been validated in Chinese populations [10] [11] [12] . The application of the EQ-5D-3L questionnaire in China, however, is restricted because there was no Chinese value set. The purpose of this study was to establish an EQ-5D-3L value set for China using TTO values for 97 EQ-5D-3L health states directly elicited from the general population in China.
Methods

Sampling Design
A convenience general population sample was recruited from five cities of China: Beijing, Guangzhou, Shenyang, Nanjing, and Chengdu. The cities are roughly located in centers of the most populous areas of the nation including north, northeast, east, south, and southwest. The target sample size for each city was 240, and quotas were set to make sure that the age and sex distributions of the sample resembled those of the national Chinese population in 2009 [13] . Age and sex were found to be the major demographic characteristics affecting health preferences [14, 15] .
The Valuation Interview
One-on-one, face-to-face interviews were conducted by trained interviewers in the homes of participants. The Paris protocol [16] , which represented an improvement of the Measurement and Valuation of Health (MVH) protocol [17] , was used in this study. After a brief introduction to the purpose of the study, the interviewer asked the respondents to complete the following tasks: 1) describe their own health using the EQ-5D-3L questionnaire descriptive system; 2) rank 13 EQ-5D-3L health states in terms of their severity; 3) rate the 13 health states using a vertical, hashmarked visual analog scale; 4) answer the TTO questions designed for the 13 health states (i.e., TTO valuation exercise); and 5) answer questions assessing sociodemographic and health characteristics.
As in previous studies of this kind, tasks 1 to 3 were used to familiarize participants with the health states. Each health state was presented in a separate card on which text describing the health state was printed, and a visual aid was used in the TTO exercise to illustrate the different lengths of hypothetical lives. In the TTO valuation exercise, participants were first asked to rate whether a health state was better than, equivalent to, or worse than death. If a state was considered better than death, a series of questions were asked to find out the number of years (t) at which the respondent was indifferent between t years of life in full health and 10 years of life in that state. The TTO value for that state was estimated as t/10 (0 o t r 10). The TTO value for states considered as bad as death was 0. If a state was considered worse than death, the number of years (t) at which the respondent was indifferent between a life of (10 À t) years in that state followed by t years in full health and death was elicited using a series of questions. The TTO value was Àt/(10 À t).
The survey was performed from March 11 to May 25, 2011. A total of 106 faculty members, and graduate and undergraduate students recruited from five universities located in the study sites were used as interviewers. All the interviewers participated in a standard training workshop and practiced their interview skills in mock interviews with each other and in a pilot study.
Selection of Health States for Valuation
Each EQ-5D-3L health state can be coded into a five-digit number using the numbers 1 (no problems), 2 (some/moderate problems), and 3 (extreme problems) to indicate the functional levels of the five dimensions of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression in the state. For example, 21223 stands for a state of having some problems in mobility and usual activities, moderate pain/discomfort, and extreme anxiety/depression.
As in a previous study conducted by Lee et al. [15] , we followed the Paris protocol proposed by Paul Kind rather than the MVH protocol to select EQ-5D-3L health states to be valued. Based on the assumption that more health states would provide better estimation, the Paris protocol proposed to directly value a total of 101 EQ-5D-3L health states for estimating a EQ-5D-3L value set. In the present study, we included 97 of those health states and divided them into eight blocks, with each block comprising three "mild" states, 6 "moderate" states, and 3 "severe" states (Table 1) . Mild states were health states in which dimensions were either in level 1 (no problems) or in level 2 (some/moderate problems) such as the state 12221; severe states were health states in which dimensions were either in level 2 or in level 3 (extreme problems) such as the state 33222; all other EQ-5D-3L states were considered as moderate states. In this study, each participant was randomly assigned one block of states plus the state 33333 for valuation.
Data Analysis
Transformation of negative values
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states worse than death, namely, monotonic, linear, and truncation transformation. Because none of the methods is rooted in any utility theories, none of them is the best. Therefore, we applied all three methods to identify the one performing the best with our data. The formula used by the monotonic method and the linear method was -t/10 and Àt/[(10 À t) Â 19], respectively.
Modeling of TTO values
The main analysis in this study was modeling of the TTO values using various linear regression models. We used three types of dependent variables that were used in previous EQ-5D-3L questionnaire valuation studies: 1) disutility (1 minus the utility); 2) the difference in values between "33333" and the particular state; and 3) logarithm of disutility. Using the MVH data, Dolan found that method 2 led to better modeling results than did method 1, while Jo et al. [19] found that method 3 performed better than method 1 in a valuation study in South Korea. Four types of model specifications were estimated in our study: 1) the main effects model; 2) the N3 model; 3) the D1 model; and 4) the "difference" model. The main effects model included 10 dummy variables for specifying the problems in a state, with the MO2, SC2, UA2, PD2, and AD2 terms being 1 (0) for the presence (absence) of level 2 problems in mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, respectively, and the MO3, SC3, UA3, PD3, and AD3 being 1 (0) for the presence (absence) of level 3 problems in those dimensions [14] . The N3 model was model 1 plus the N3 term, which was a dummy variable whose value was 1 if any level 3 problems were present in a state and 0 if otherwise [15, 20] . The D1 model was model 1 plus D1, I2, (I2) 2 , I3, and (I3) 2 , terms in which D1 was the number of dimensions with problems beyond the first, I2 and I3 were the number of dimensions at level 2 or level 3 beyond the first, respectively, and (I2) 2 and (I3) 2 were the square of I2
and I3 [21] , respectively. The difference model comprised a set of dummy variables indicating the presence of level 1 or level 2 in a given dimension of a state, while the dependent variable was the value difference between the state and "33333" [22] . It should be noted that the utility values may be a function of the interactions between the main effects. Models with these interaction terms, however, suffered from multicollinearity. Moreover, the inclusion of a large number of first-order interaction effects may introduce the risk that some become significant purely by chance [14, 21] . Such interaction terms were usually excluded from modeling analysis in previous studies.
The study was conducted at both aggregate and individual levels. In the aggregate-level analysis, the mean values of the 97 health states were calculated and modeled using both ordinary least square (OLS) and weighted least square (WLS, where the number of respondents who rated a particular state was the weight) estimators; in the individual-level analysis, the individual TTO values from all participants were pooled and modeled using the OLS and fixed-effect (FE)/random-effect (RE) estimators. The FE/RE models were used because each participant contributed 13 TTO values in this analysis. In the RE model, the individual subject effect was estimated for the intercept only, while in the FE model, the individual subject effect was estimated for all independent variables. All statistical analyses were conducted using STATA/SE 11.2.
Given the alternative models and variables, certain criteria were formulated to identify the best-performing model including 1) predictive ability, that is, the difference between the observed and the estimated values or mean absolute error (MAE), and the number of prediction errors greater than 0.05 and 0.10, respectively; 2) the sign and significance of regression coefficients; for example, the main effects should be positive when disutility was used as the dependent variable and the coefficients should be statistically significant; 3) logical consistency, specifically, if state A is superior to state B in one or more dimensions and not inferior in any other dimension, the estimated value for state A should be no lower than that for state B; 4) parsimony, that is, if the performances of several models were similar, the most parsimonious model would be preferred [20, 23] . For guiding model selection according to the first criteria, all models were estimated using a subset of randomly selected two thirds of the participants and then used to predict values for the remaining one third of the participants.
Results
Logical Inconsistencies in TTO Evaluation
The way the 97 health states were assigned into eight blocks allowed the examination of within-individual logical inconsistence in TTO valuation for 301 pairs of health states, with an average of 38 pairs for each individual. Of the 1218 participants who did not give all the states the same value, 813 participants (66.8%) did not give any logically inconsistent TTO values. Poor data quality was observed in a total of 71 participants (5.8%) who violated logical consistency for more than four pairs of states. At the aggregate level, the means of the 97 health states did not show any logical inconsistency in pairwise comparison of the health states.
Sample Characteristics
Of 1222 participants who were successfully interviewed, 75 participants were excluded because of more than four logically inconsistent values (N ¼ 71) or assignment of the same value to all states (N ¼ 4). The final sample included 1147 participants. The sex and age distributions of participants in the final sample were similar to those of the Chinese population in China. The majority of the participants in the final sample were Han nationals (96.2%), females (50.3%), and graduates from at least a senior high school (82.0%). The mean age of the participants in the final sample was 43.3 years, and the average interview time was 43.1 minutes (median 40.0 minutes). The characteristics of participants in the final sample were largely similar to those who were excluded from the study except that those excluded participants were slightly younger and reported slightly better health status and lifestyles. The full sociodemographic and health-related characteristics of the final and excluded samples are presented in Table 2 .
Modeling of TTO Values
The linear transformation approach to rescaling negative values consistently yielded smaller prediction errors than did the monotonic and truncated transformation approaches regardless of the dependent variable (disutility, the difference in values compared with "33333," or logarithm of disutility), model specification (the main effects, N3, or D1), or model estimator (OLS, FE, or RE at the individual level, or OLS and WLS at the aggregate level) used. For example, when disutility was regressed on the main effects terms and the model was estimated using individual-level data with the RE estimator, the number of health states for which the absolute prediction error was greater than 0.05 (or 0.10) was 9, 21, and 29 (or 0, 2, and 4) when the linear, monotonic, and truncated approach was used to transform the negative values, respectively. Hence, the linear transformation approach was used in the final analysis.
Models using disutility as the dependent variable performed better than did those using the logarithm of disutility and not worse than did those using the difference from the "33333" in terms of predictive ability. Therefore, disutility was adopted as the dependent variable in the final analysis. Tables 3 and 4 present the parameter estimates and goodness-of-fit results for the main effects, N3, and D1 models at individual level and aggregate level, respectively. In the individual-level data analysis, the Hausman test did not reject the null hypothesis (χ 2 ¼ 6.24, P ¼ 0.7951);
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therefore, the results of the OLS and RE estimation rather than FE estimation were reported in Table 3 . All the models estimated using either OLS or RE regression had an MAE lower than 0.02, with no less than 10 health states for which the absolute error in prediction exceeded 0.1 and 0.05, respectively. None of the models for the individual-level data (models 1-6), however, passed the Jarque-Bera test for normality of the residuals (P o 0.001).
Results from modeling of aggregate-level data (models 7-12, Table 4 ) were similar to those from modeling of individual-level data. At the aggregate level, models estimated using OLS and WLS regression generated similar results. Among those, the N3 model based on OLS regression (model 8) resulted in 0 and 7 health states for which the absolute error in prediction exceeded 0.1 and 0.05, respectively, and the MAE of 0.020, which was the best prediction results among all the models tested. 
Discussion
Economic evaluation has been increasingly used to inform decision making in health care resources allocation. In China, the central government has pledged to use pharmacoeconomic evaluations to guide the pricing of new, patented drugs [24] and the EQ-5D-3L questionnaire is endorsed as a suitable instrument for measuring QALYs in CUA [9] . The use of this instrument in China, however, necessitates having values for the health states from the Chinese population. In this study, we determined the values of the EQ-5D-3L health states from the perspective of the Chinese people. This is the first effort to develop standardized utility-measuring tools for conducting economic evaluations in the world's most populous country. Hence, this study represents an important milestone in the development of health technology assessment in China.
Because there is no criterion standard method for valuing hypothetical health states, the validity of the EQ-5D-3L values estimated in our study cannot be directly assessed. Nevertheless, the result that more severe health problems were associated with greater disutility values exhibited in all linear regression models support the construct validity of the utility values. Also, the EQ-5D-3L values as predicted by model 8 are highly correlated with those estimated from other populations [14, 15, [19] [20] [21] [22] 25, 26] using similar methods (see Appendix 1 in Supplemental Materials found at http://dx.doi.org/10.1016/j), indicating convergent construct validity. Moreover, the modeling results are similar to those from previous EQ-5D-3L valuation studies. The data fit all the model specifications used in previous valuation studies well, and the best model fit and the range of predicted values in this study were similar to those in previous studies (see Appendix 1 in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval. 2014.05.007). These similarities may also be treated as evidence for the validity of the value set developed.
A prominent feature of the present study is direct valuation of 40% of the 243 EQ-5D-3L health states. By adopting the Paris protocol, we valued a total of 97 EQ-5D-3L states; in contrast, most previous studies used the MVH protocol to value only 42 EQ-5D-3L health states. The Paris protocol was developed by Paul Kind, the main investigator of the MVH study, to replace the 12-year-old MVH protocol. The main feature of the Paris protocol is to value an increased number of EQ-5D-3L states [16] . Theoretically, the more states valued directly, the fewer states for which values have to be estimated purely on the basis of modeling (i.e., smaller interpolation space) and hence higher prediction accuracy. Before the present study, the Paris protocol was successfully implemented in South Korea [15] . One advantage of using the Paris protocol is the opportunity to model the means of the valued health states. This would not be optimal for studies using the MVH because only 17% of the 243 states were valued. Interestingly, the model based on aggregate-level data outperformed the model based on individual-level data in both the Korean study and the present study, suggesting that the former may be a better modeling approach than the latter. The better model fit of the aggregate-level data should be due to the elimination of the individual-level data variability. This was not a disadvantage, however, because the purpose of the modeling was to predict the population values of the health states but not the values of individual respondents. Rather, the aggregate-level modeling could be an advantage as the OLS algorithm is sufficient for model estimation. Therefore, this study supports the use of the Paris protocol and the conduct of aggregate-level modeling in future EQ-5D-3L valuation studies.
In this study, we excluded participants whose valuations violated the utility theory from our analysis for estimating the social values of the EQ-5D-3L states. Logically inconsistent values suggested that those participants failed to either understand or concentrate on the valuation questions. Therefore, as some of the previous health state valuation studies did [19, 27] , we excluded some of those participants who gave multiple logically inconsistent responses. It should be noted that many EQ-5D valuation studies did not exclude logically inconsistent values and that Lamers et al. [28] found that inconsistent data did not have important effects on the modeling results when estimating the EQ-5D values. Nevertheless, we elected to exclude inconsistent participants to achieve more accurate and reliable predictions. We postulated that the main reason for the logical inconsistency in our study was poor concentration because those participants were relatively young and well educated.
The main limitation of the present study was the sampling method used. We were unable to conduct probabilistic sampling because of resource constraints. All participants of the study were recruited from big cities. Because of the socioeconomic differences between cities and rural areas in China, health preferences of residents in cities and rural areas may differ. Also, the majority of the participants were of Han nationality; minority nationalities in China who account for 9% of the population may have different health preferences. Future health state valuation studies should target rural and minority populations in the country.
Despite the limitations, the EQ-5D-3L value set we developed using a general Chinese population sample provides health services researchers and policymakers with a convenient tool for conducting economic evaluation of health technologies in China. This study is the first attempt to develop a standardized instrument for quantifying QALYs in China.
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